Financials data is unavailable for this security.
View more
Year on year Danaher Corp 's revenues fell -10.33% from 26.64bn to 23.89bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 7.21bn to 4.76bn, a -33.92% decrease.
| Gross margin | 59.26% |
|---|---|
| Net profit margin | 16.57% |
| Operating margin | 20.24% |
| Return on assets | 4.67% |
|---|---|
| Return on equity | 7.59% |
| Return on investment | 5.19% |
More ▼
Cash flow in USDView more
In 2023, Danaher Corp did not generate a significant amount of cash. However, the company earned 7.16bn from its operations for a Cash Flow Margin of 29.99%. In addition the company used 7.08bn on investing activities and also paid 273.00m in financing cash flows.
| Cash flow per share | 8.35 |
|---|---|
| Price/Cash flow per share | 27.45 |
| Book value per share | 71.03 |
|---|---|
| Tangible book value per share | -14.85 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.37 |
|---|---|
| Quick ratio | 1.01 |
| Total debt/total equity | 0.3416 |
|---|---|
| Total debt/total capital | 0.2546 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share increased 10.42% while earnings per share excluding extraordinary items fell by -33.26%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.39% |
|---|---|
| Div growth rate (5 year) | 11.32% |
| Payout ratio (TTM) | 19.50% |
| EPS growth(5 years) | 10.83 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -10.96 |
More ▼
